secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spectral AI, Inc. (MDAI)
CIK:        0001833498
Form:       8-K
Filed at:   2026-09-15T20:03:22+00:00
Accession:  0001213900-26-100119
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Spectral AI posts investor presentation: $250M+ gov funding, UKCA approval, FDA De Novo in wound-care AI
--------------------------------------------------------------------------------

- Posted updated investor presentation Sept 14, 2026 highlighting DeepView AI+multispectral imaging platform for wound care.
- Cites 13-year milestone track record backed by $250M+ in non-dilutive government funding from 2013-2026.
- Regulatory progress includes UKCA approval and FDA De Novo pathway; DeepView supports multiple indications.
- DeepView predicts wound healing in seconds during initial patient visit; company prioritizing profitable markets for near-term commercialization.
- Extensive patent portfolio, trade secrets and truthed images cited as competitive barriers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1833498/000121390026100119/0001213900-26-100119-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1833498/000121390026100119/ea0305581-8k_spectral.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-100119

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer